Multi-Gene Assays Now Recommended To Refine Chemotherapy Decisions in Breast Cancer

11th Annual Palm Beach Cancer Symposium (April 3-4, 2009 Hollywood, Florida)—Peter Goodwin interviews Kathy Albain, Professor of Medicine at Loyola University, Chicago, on her return from the 2009 St Gallen consensus meeting which formulated updated recommendations about adjuvant therapy for breast cancer. The 21 gene recurrence score and the 70-gene profiling assay have now been endorsed by this Swiss meeting as significant contributors to the decision making process on cytotoxic chemotherapy for patients with estrogen receptor positive disease, including both node negative and node positive early breast cancer.

You can listen to Multi-Gene Assays Now Recommended To Refine Chemotherapy Decisions in Breast Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

Multi-Gene Assays Now Recommended To Refine Chemotherapy Decisions in Breast Cancer is an episode from Oncology Times Broadcast News.

This episode is 00:07:15 long.

This episode was published on Sep 28, 2009.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Oncology Times Broadcast News when more episodes are available from the podcast feed.